Perioperative cangrelor in patients with recent percutaneous coronary intervention undergoing liver transplantation: A case series.
Luma SuccarChelsea N LopezDavid W VictorScott A LindbergAshish SahariaSamar ShethConstance M MobleyPublished in: Pharmacotherapy (2022)
The use of cangrelor as bridge therapy in high-risk perioperative liver transplant patients appears to be a viable option when DAPT is warranted.
Keyphrases
- percutaneous coronary intervention
- end stage renal disease
- cardiac surgery
- antiplatelet therapy
- patients undergoing
- ejection fraction
- newly diagnosed
- chronic kidney disease
- coronary artery disease
- acute coronary syndrome
- peritoneal dialysis
- prognostic factors
- st segment elevation myocardial infarction
- stem cells
- heart failure
- st elevation myocardial infarction
- acute kidney injury
- left ventricular
- patient reported